IPO Boutique

Nevro IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Nevro, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
NevroNVRO -
NYSE
$15.00-$17.00 $18.00 $23.407 million11/6/2014
J.P. Morgan, Morgan Stanley
Co-Manager(s):
Leerink Partners, JMP Securities
Health Care
Filing(s):

Filed 2014-10-03
Terms Added 2014-10-27



Nevro Quote & Chart - Click for current quote - NVRO

About Nevro (adapted from Nevro prospectus):
They are a medical device company that has developed and commercialized an innovative neuromodulation platform for the treatment of chronic pain.

This description is adapted from Nevro prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Nevro "NVRO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved